These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 18455123)
1. Regulation of in situ to invasive breast carcinoma transition. Hu M; Yao J; Carroll DK; Weremowicz S; Chen H; Carrasco D; Richardson A; Violette S; Nikolskaya T; Nikolsky Y; Bauerlein EL; Hahn WC; Gelman RS; Allred C; Bissell MJ; Schnitt S; Polyak K Cancer Cell; 2008 May; 13(5):394-406. PubMed ID: 18455123 [TBL] [Abstract][Full Text] [Related]
2. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126 [TBL] [Abstract][Full Text] [Related]
3. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence. Allen MD; Thomas GJ; Clark S; Dawoud MM; Vallath S; Payne SJ; Gomm JJ; Dreger SA; Dickinson S; Edwards DR; Pennington CJ; Sestak I; Cuzick J; Marshall JF; Hart IR; Jones JL Clin Cancer Res; 2014 Jan; 20(2):344-57. PubMed ID: 24150233 [TBL] [Abstract][Full Text] [Related]
4. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function. Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493 [TBL] [Abstract][Full Text] [Related]
5. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063 [TBL] [Abstract][Full Text] [Related]
6. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525 [TBL] [Abstract][Full Text] [Related]
7. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s). Scribner KC; Behbod F; Porter WW Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354 [TBL] [Abstract][Full Text] [Related]
8. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion. Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318 [TBL] [Abstract][Full Text] [Related]
9. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion. Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922 [TBL] [Abstract][Full Text] [Related]
10. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions. Mardekian SK; Bombonati A; Palazzo JP Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418 [TBL] [Abstract][Full Text] [Related]
11. Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness. Zheng ZY; Elsarraj H; Lei JT; Hong Y; Anurag M; Feng L; Kennedy H; Shen Y; Lo F; Zhao Z; Zhang B; Zhang XH; Tawfik OW; Behbod F; Chang EC Breast Cancer Res; 2022 Oct; 24(1):68. PubMed ID: 36258226 [TBL] [Abstract][Full Text] [Related]
12. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells. Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373 [TBL] [Abstract][Full Text] [Related]
13. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin. Schnitt SJ Breast Cancer Res; 2009; 11(1):101. PubMed ID: 19291276 [TBL] [Abstract][Full Text] [Related]
14. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression. Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330 [TBL] [Abstract][Full Text] [Related]
15. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Bijker N; Peterse JL; Duchateau L; Robanus-Maandag EC; Bosch CA; Duval C; Pilotti S; van de Vijver MJ Br J Cancer; 2001 Feb; 84(4):539-44. PubMed ID: 11207051 [TBL] [Abstract][Full Text] [Related]
16. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
17. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207 [TBL] [Abstract][Full Text] [Related]
18. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
19. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623 [TBL] [Abstract][Full Text] [Related]
20. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer. Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]